FDA Permits Production Of Generic Heroin Drug Against Bid Of Reckitt

by Dr. Rich on February 27, 2013

Two generic forms of Reckitt Benckiser’s heroin addiction medication have been approved by U.S. regulators, rejecting the company’s bid to prevent rival products based on their belief that stricter regulations were needed on packages to better protect children. Reckitt Benckiser, a British consumer health products company, makes a good portion of its earnings from Suboxone, a medication that has buprenorphine and helps people who are addicted to opiates deal with withdrawal symptoms when they quit… (Source: Health News from Medical News Today)

MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest addiction news and research.

Previous post:

Next post: